Based on the Stevanato Group SpA stock forecast from 4 analysts, the average analyst target price for Stevanato Group SpA is USD 24.19 over the next 12 months. Stevanato Group SpA’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Stevanato Group SpA is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Stevanato Group SpA’s stock price was USD 23.32. Stevanato Group SpA’s stock price has changed by +3.74% over the past week, +3.00% over the past month and +13.65% over the last year.
No recent analyst target price found for Stevanato Group SpA
No recent average analyst rating found for Stevanato Group SpA
Company Overview Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass forming machines; and after-sales services, such as spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug product, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L. Read Less
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segmen...Read More
Frequently Asked Questions About Stevanato Group SpA (STVN) Stock
Based on ratings from 4 analysts Stevanato Group SpA's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 6 hold ratings.
STVN stock's dividend yield is 0.26%.
Our analysis grades STVN stock's dividend yield at F. This means that STVN stock's dividend yield is above 11% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this STVN may be a poor dividend stock for its sector.
Based on targets from 4 analysts, the average taret price for STVN is USD 24.19 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 23.
STVN stock's Price/Earning ratio is 46.62.
Our analysis grades STVN stock's Price / Earning ratio at F. This means that STVN stock's Price/Earning ratio is above 62% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this STVN may be a overvalued for its sector.
The last closing price of STVN's stock was USD 23.32.
The most recent market capitalization for STVN is USD 5.98B.
Based on targets from 4 analysts, the average taret price for STVN is projected at USD 24.19 over the next 12 months.
This means that STVN's stock price may go up by +3.72% over the next 12 months.
We can't find any ETFs which contains Stevanato Group SpA's stock.
As per our most recent records Stevanato Group SpA has 5,521 Employees.
Stevanato Group SpA's registered address is Via Molinella 17, Piombino Dese, PD, Italy, 35017.
You can get more information about it from Stevanato Group SpA's website at https://www.stevanatogroup.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Stevanato Group SpA (STVN) Stock
Based on ratings from 4 analysts Stevanato Group SpA's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 6 hold ratings.
STVN stock's dividend yield is 0.26%.
Our analysis grades STVN stock's dividend yield at F. This means that STVN stock's dividend yield is above 11% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this STVN may be a poor dividend stock for its sector.
Based on targets from 4 analysts, the average taret price for STVN is USD 24.19 over the next 12 months. The maximum analyst target price is USD 28 while the minimum anlayst target price is USD 23.
STVN stock's Price/Earning ratio is 46.62.
Our analysis grades STVN stock's Price / Earning ratio at F. This means that STVN stock's Price/Earning ratio is above 62% of the stocks in the Medical Instruments & Supplies sector in the NYE exchange.
Based on this STVN may be a overvalued for its sector.
The last closing price of STVN's stock was USD 23.32.
The most recent market capitalization for STVN is USD 5.98B.
Based on targets from 4 analysts, the average taret price for STVN is projected at USD 24.19 over the next 12 months.
This means that STVN's stock price may go up by +3.72% over the next 12 months.
We can't find any ETFs which contains Stevanato Group SpA's stock.
As per our most recent records Stevanato Group SpA has 5,521 Employees.
Stevanato Group SpA's registered address is Via Molinella 17, Piombino Dese, PD, Italy, 35017.
You can get more information about it from Stevanato Group SpA's website at https://www.stevanatogroup.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for STVN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
